Login

Financial Snapshot

Revenue
TTM
$2.657B
Gross Margin
TTM
44.89%
Net Income
TTM
-$1.211B
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
143.08%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.851B
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$159.4M

Stock Price

Loading...
Market Cap: $906.26 Million

About QuidelOrtho Corp

QuidelOrtho Corp (NASDAQ: QDEL) is a diagnostics company. The filing excerpts provided do not contain sufficient detail to construct a fully sourced canonical description covering revenue model, segment breakdown, competitive position, headquarters, founding year, or leadership from the 10-K filed 2026-02-19 (accession 000190632426000008). The excerpts include only cover page boilerplate, a table of contents, and forward-looking statement disclosures. No business narrative, financial data, product descriptions, customer information, or geographic data are present in the supplied text. A sourced description cannot be generated without that underlying content.

Source: SEC 10-K, filed 2026-02-19

Industry: In Vitro & In Vivo Diagnostic Substances Peers: Align Technology Inc Cooper Companies Inc DENTSPLY SIRONA Inc Haemonetics Corp ICU Medical Inc Lantheus Holdings Inc Neogen Corp STAAR Surgical Co

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support